Market cap
₹460 Cr
NSE: ALBERTDAVD | BSE: 524075
₹806.45
As on 06-May-2026IST
Market cap
₹460 Cr
Revenue (TTM)
₹323 Cr
P/E Ratio
47.9
P/B Ratio
1.1
Div. Yield
0.6 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹10 Cr
ROE
4.4 %
ROCE
6.5 %
Industry P/E
30.43
EV/EBITDA
18.9
Debt to Equity
0
Book Value
₹717
EPS
₹16.8
Face value
10
Shares outstanding
5,707,162
CFO
₹284.64 Cr
EBITDA
₹279.81 Cr
Net Profit
₹305.80 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Albert David
| 9.5 | 23.2 | 16.0 | -4.2 | 12.6 | 12.4 | -- |
|
BSE Healthcare
| 6.4 | 11.7 | 9.7 | 9.1 | 26.0 | 14.0 | 11.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Albert David
| -45.0 | 37.2 | 72.1 | -6.3 | 34.1 | 6.9 | -1.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Albert David
|
806.5 | 460.1 | 322.6 | 9.6 | -3.4 | 2.4 | 47.9 | 1.1 |
| 3,096.3 | 38,645.7 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 36.6 | 8.5 | |
| 8,382.5 | 20,923.6 | 2,177.5 | 200.9 | 11.3 | 26.5 | 104.2 | 25.2 | |
| 1,841.3 | 13,982.4 | 2,089.5 | 622.0 | 31.3 | 20.4 | 22.8 | 4.2 | |
| 1,371.9 | 19,001.2 | 3,078.2 | 469.4 | 26.4 | 14.9 | 44 | 5.2 | |
| 2,141.5 | 34,370.0 | 4,193.0 | 753.8 | 22.7 | 20.8 | 45.6 | 8.6 | |
| 4,783.2 | 21,875.9 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.6 | 5.5 | |
| 5,338.5 | 8,854.2 | 1,348.5 | 293.5 | 28.1 | 50.7 | 30.2 | 12.7 | |
| 441.9 | 8,646.7 | 1,432.0 | 149.0 | 19.1 | 7.9 | 57.6 | 3.5 | |
| 1,098.0 | 10,127.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 19.8 | 3.4 |
No Review & Analysis are available.
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol,... gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India. Read more
Incorporated
1938
Chairman
Arun Kumar Kothari
Managing Director
--
Headquarters
Kolkata, West Bengal
Website
Annual Reports
The share price of Albert David Ltd is ₹806.45 (NSE) and ₹806.25 (BSE) as of 06-May-2026 IST. Albert David Ltd has given a return of 12.64% in the last 3 years.
The P/E ratio of Albert David Ltd is 47.88 times as on 06-May-2026, a 57 premium to its peers’ median range of 30.43 times.
The P/B ratio of Albert David Ltd is 1.12 times as on 06-May-2026, a 76 discount to its peers’ median range of 4.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
26.92
|
1.18
|
|
2024
|
8.14
|
1.60
|
|
2023
|
8.08
|
0.94
|
|
2022
|
8.61
|
1.09
|
|
2021
|
9.71
|
0.88
|
The 52-week high and low of Albert David Ltd are Rs 957.50 and Rs 579.90 as of 06-May-2026.
Albert David Ltd has a market capitalisation of ₹ 460 Cr as on 06-May-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Albert David Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.